TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

By Hoppensteadt D.A.   Walenga J.M.   Fasanella A.   Jeske W.   Fareed J.  

Thrombosis Research, Vol. 77, Iss. 2, 1995-01 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite

Plasma Tissue Factor Pathway Inhibitor and Tissue Factor Antigen Levels After Administration of Heparin in Patients With Angina Pectoris - Relationship between free and endothelial cell-associated forms of TFPI

By Soejima H.   Ogawa H.   Yasue H.   Nishiyama K.   Kaikita K.   Misumi K.   Takazoe K.   Kugiyama K.   Tsuji I.   Kumeda K.   Nakamura S.  

Thrombosis Research, Vol. 93, Iss. 1, 1999-01 ,pp. : 17-25

Elsevier

Access to resources Recommend Favorite

Heparin-Releasable Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (Tfpi) is Increased in the Coronary Circulation After Coronary Spasm in Patients with Coronary Spastic Angina - Evidence for association with and regulation by LDL in human plasma

By Nishiyama K.   Ogawa H.   Yasue H.   Soejima H.   Misumi K.   Kugiyama K.   Tsuji I.   Kumeda K.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

THE EFFECT OF HEPARIN AND ITS NEUTRALISATION ON FUNCTIONAL ASSAYS FOR FACTOR VIIa, FACTOR VII AND TFPI

By Cardigan R.A.   Mackie I.J.   Machin S.J.  

Thrombosis Research, Vol. 84, Iss. 4, 1996-11 ,pp. : 237-242

Elsevier

Access to resources Recommend Favorite

Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction - Proposed heparin recognition region

By Ye Z.   Takano R.   Hayashi K.   Ta T.-V.   Kato H.   Kamikubo Y.   Nakahara Y.   Kumeda K.   Hara S.  

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite